Little Benefit in Adding Ultrasound to Screening Mammography
(MedPage Today) -- Challenges widespread use of ultrasound for dense breasts (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 22, 2019 Category: Hematology Source Type: news

ER Doc Survives Cancer, Now Must Survive ER ER Doc Survives Cancer, Now Must Survive ER
A Florida-based ER physician with an aggressive lymphoma underwent a'miracle'treatment but now has a weakened immune system. Back at work, now he has to survive the ER and its germs.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - March 22, 2019 Category: Internal Medicine Tags: Hematology-Oncology News Source Type: news

' Cancer' Label for Low-Risk Lesions Could Lead to Overtreatment'Cancer' Label for Low-Risk Lesions Could Lead to Overtreatment
Using the term'cancer'to describe low-risk lesions rather than a more benign word could tip patients into paradoxical treatment choices that worsen their prognosis because of fear, say US researchers.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 22, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Radical Opioid Restriction Works for Postoperative Patients Radical Opioid Restriction Works for Postoperative Patients
An ultrarestrictive opioid prescription protocol radically reduces postoperative opioid use in patients with gynecological cancer who do not have compromising outcomes.Medscape Medical News (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - March 22, 2019 Category: Surgery Tags: Hematology-Oncology News Source Type: news

Morning Break:'Snapchat Dysmorphia'; Snoring Life Away; A Fertility First
(MedPage Today) -- Health news and commentary from around the Web gathered by the MedPage Today staff (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 22, 2019 Category: Hematology Source Type: news

St. Louis Symphony Lowers Blood Pressure, Eases Chemo St. Louis Symphony Lowers Blood Pressure, Eases Chemo
A cancer center in Missouri has the good fortune to be visited by two professional musicians from a renowned symphony once a month. So they did a study on the effect of the music.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 22, 2019 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Atezolizumab Safe in Advanced Urothelial Cancer Atezolizumab Safe in Advanced Urothelial Cancer
The SAUL phase 3b trial met its primary safety endpoint, but the comparative efficacy of the anti-PD-L1 agent in a broader population is still up in the air.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 22, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Neuroticism a Drag on Prostate Ca Outcomes
(MedPage Today) -- Selected presentations from the European Association of Urology congress (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 22, 2019 Category: Hematology Source Type: news

Breast Implant ALCL: Excellent Prognosis if Treated Promptly Breast Implant ALCL: Excellent Prognosis if Treated Promptly
Clinicians encouraged to follow 2019 NCCN guidelines, discuss risks, symptoms as part of patient consent for textured breast implants.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 21, 2019 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Program Improves Communication Between Oncology Clinicians and Patients Program Improves Communication Between Oncology Clinicians and Patients
The Serious Illness Care Program helps oncologists have better serious-illness conversations with patients without creating anxiety or depression, according to results of a cluster-randomized clinical trial.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 21, 2019 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Liquid Biopsy Spots Early Liver Cancer in Patients With HBV Infection Liquid Biopsy Spots Early Liver Cancer in Patients With HBV Infection
In high-risk patients with asymptomatic hepatitis B virus (HBV) infection, a liquid biopsy shows promise in detecting early-stage hepatocellular carcinoma (HCC), according to Chinese and U.S. researchers.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - March 21, 2019 Category: Pathology Tags: Hematology-Oncology News Source Type: news

Is Alex Trebek's Life in Jeopardy?
(MedPage Today) -- What a stage 4 diagnosis means for the game show host (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 21, 2019 Category: Hematology Source Type: news

Worry After Prostatectomy a Self-fulfilling Prophecy Worry After Prostatectomy a Self-fulfilling Prophecy
Three years after a radical prostatectomy, men with the personality trait of neuroticism scored worse on urinary, bowel, sexual, and hormonal domains.Medscape Medical News (Source: Medscape Urology Headlines)
Source: Medscape Urology Headlines - March 21, 2019 Category: Urology & Nephrology Tags: Hematology-Oncology News Source Type: news

Beckman Coulter's Compact, Low-volume Hematology Analyzer Receives FDA 510(k) Clearance
With just 17 microliters of blood, the DxH 520 enables low-volume laboratories to deliver 5-part differential test results in 60 seconds or less BREA, Calif., March 21, 2019 -- (Healthcare Sales & Marketing Network) -- Beckman Coulter, a global leader ... Devices, Diagnostics, FDA Beckman Coulter, DxH 520, hematology analyzer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 21, 2019 Category: Pharmaceuticals Source Type: news

' Optimistic' Longer-term Outcomes for Metastatic Melanoma'Optimistic' Longer-term Outcomes for Metastatic Melanoma
Targeted therapy and immunotherapy are showing promising longer-term outcomes in metastatic melanoma. Dr Weber reviews two new studies.Medscape Oncology (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - March 21, 2019 Category: Allergy & Immunology Tags: Hematology-Oncology Commentary Source Type: news

To Treat and Prevent Brain Mets, Use Best Therapy Up Front To Treat and Prevent Brain Mets, Use Best Therapy Up Front
Use newer, more effective targeted therapies first when possible to treat and stave off brain metastases in oncogene-driven lung cancers, says Mark Kris.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 21, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Clinical Trials of Venetoclax in Myeloma Stopped Due to Deaths Clinical Trials of Venetoclax in Myeloma Stopped Due to Deaths
The FDA issued a partial hold on all ongoing clinical trials evaluating venetoclax in multiple myeloma because of an excessive number of deaths seen in the BELLINI study.News Alerts (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 21, 2019 Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news

Clinical Trials With Venetoclax on Hold Because of Deaths Clinical Trials With Venetoclax on Hold Because of Deaths
The FDA issued a partial hold on all ongoing clinical trials evaluating venetoclax in multiple myeloma because of an excessive number of deaths seen in the BELLINI study.News Alerts (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 21, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

Tumor Radiomic Features Can Predict NSCLC Chemo Response
(MedPage Today) -- Peritumoral texture features on baseline CT may reflect tumor microenvironment (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 20, 2019 Category: Hematology Source Type: news

Potential Game Changer for Endometrial Cancer
(MedPage Today) -- A 30% response rate in recurrent/advanced disease, 49% in MSI-H tumors (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 20, 2019 Category: Hematology Source Type: news

Carbon-Ion RT May Cut Risk for Subsequent Tumors in Prostate Ca
(MedPage Today) -- Hypothesis-generating study needs more validation (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 20, 2019 Category: Hematology Source Type: news

Severe Adverse Events When Osimertinib Follows Immunotherapy Severe Adverse Events When Osimertinib Follows Immunotherapy
Severe immune-related adverse events have been observed when osimrtinib was given after, but not before, immune checkpoint inhibitors in patients with advanced NSCLC.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 20, 2019 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Geriatric Oncology Guidelines Must Be Tailored to Resources Geriatric Oncology Guidelines Must Be Tailored to Resources
Yes, elderly patients with cancer are different in many ways from younger patients, but geriatric oncology guidelines need to take into account the resources available to them, not just their age.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 20, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

No Elevated Cancer Risk for RA Patients With Tocilizumab (CME/CE)
(MedPage Today) -- Combined risk for new cancers except non-melanoma skin cancer with IL-6r inhibitor not significantly different than with TNF inhibitors (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 20, 2019 Category: Hematology Source Type: news

Overturning Dogma -- Using Testosterone in Prostate Cancer Overturning Dogma -- Using Testosterone in Prostate Cancer
Testosterone replacement therapy decreased the risk for biochemical recurrence in some men and delayed time to recurrence in others, findings that took investigators by surprise.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 20, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Mutation Status May Drive Sequential vs Combo Treatment in CRC Mutation Status May Drive Sequential vs Combo Treatment in CRC
David Kerr reviews a new study on sequential versus combination chemotherapy for advanced colorectal cancer, asking whether this study will change readers'practice.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 20, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Tool Helps Decide Who Needs Prostate Cancer Tx Immediately Tool Helps Decide Who Needs Prostate Cancer Tx Immediately
Clinicians and patients unsure whether to opt for conservative active surveillance or radical treatment for nonmetastatic prostate cancer can use a new, novel, free online tool.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 20, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Modest Effects of Intense Therapy for Prostate Ca
(MedPage Today) -- Studies of chemotherapy, ADT add data to discussions about high-risk disease (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 20, 2019 Category: Hematology Source Type: news

Cancer Vaccine Misses Mark in Prostate Cancer
(MedPage Today) -- Phase III randomized trial fails to confirm survival benefit seen earlier (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 19, 2019 Category: Hematology Source Type: news

Early Data Send Strong Signal in Advanced Gyn Cancers
(MedPage Today) -- Clinical benefit rate tops 90% in pair of single-center studies (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 19, 2019 Category: Hematology Source Type: news

' End of the Road' for Trabectedin in Ovarian Cancer?
(MedPage Today) -- Trial stopped for futility, but 13-month OS improvement seen in patients with BRCA mutations (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 19, 2019 Category: Hematology Source Type: news

Portable Thermal Ablation Device for Cervical Precancers Portable Thermal Ablation Device for Cervical Precancers
The battery-powered device would be useful in resource-poor countries by allowing women to be screened and then treated immediately by nurses, even when there is no electricity.Medscape Medical News (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - March 19, 2019 Category: Infectious Diseases Tags: Hematology-Oncology News Source Type: news

Novel Handheld Device Detects High-Risk HPV in 2 Hours Novel Handheld Device Detects High-Risk HPV in 2 Hours
Several innovative strategies are successfully detecting high-risk human papillomavirus (HPV) types with technologies that do not require a resource-rich setting to perform well.Medscape Medical News (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - March 19, 2019 Category: Pathology Tags: Hematology-Oncology News Source Type: news

Abbott Announces CE Mark for Alinity(TM) m Diagnostics System and Assays, the Latest in Molecular Technology, to Help Deliver Critical Test Results and Benefits to Patients
Alinity m will allow labs to meet the growing demand for infectious disease testing by offering increased efficiency and market-leading speed and accuracy This new technology presents one of the most significant advancements seen in the molecular diagno... Diagnostics, Regulatory Abbott, Alinity, hematology analyzer, infectious disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 19, 2019 Category: Pharmaceuticals Source Type: news

' Fast' MRI Speeds Prostate Imaging, But Only in Expert Hands'Fast' MRI Speeds Prostate Imaging, But Only in Expert Hands
The fast technique was comparable with slower, more complex MRI techniques in cases of suspected prostate cancers, but expert image readers are essential to the process at present.Medscape Medical News (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - March 19, 2019 Category: Radiology Tags: Hematology-Oncology News Source Type: news

Psychosocial Factors Impact Cancer Surgery Outcomes Psychosocial Factors Impact Cancer Surgery Outcomes
Postop complication rates rose threefold and unplanned readmission rates sixfold in comorbid patients with two or more psychosocial risk factors.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 19, 2019 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

FDA Approves Atezolizumab for Small Cell Lung Cancer FDA Approves Atezolizumab for Small Cell Lung Cancer
The immunotherapy succeeded where so many other drugs have failed -- in extending the survival of patients with extensive-stage small cell lung cancer.FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 19, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

When PARP Inhibitors Fail in Ovarian Cancer
(MedPage Today) -- Study identifies subgroup for whom another go could be worthwhile (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 18, 2019 Category: Hematology Source Type: news

AI Reduces False Positives in Lung Cancer Screening AI Reduces False Positives in Lung Cancer Screening
A new machine learning algorithm outperformed existing methods in differentiating benign nodules from cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 18, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Statin Use Tied to Lower Colorectal-Cancer Risk After Negative Colonoscopy Statin Use Tied to Lower Colorectal-Cancer Risk After Negative Colonoscopy
Statin use is associated with a reduced risk of colorectal cancer between six and 36 months after an initial negative colonoscopy, according to a retrospective study.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - March 18, 2019 Category: Surgery Tags: Hematology-Oncology News Source Type: news

TWiST Strengthens PARP Inhibitor Role in Ovarian Cancer TWiST Strengthens PARP Inhibitor Role in Ovarian Cancer
New analysis of the NOVA trial confirms clinical benefit from niraparib for patients with recurrent ovarian cancer. The benefit occurred both in patients with and in those without BRCA mutations.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 18, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Immunotherapy Should Be First Line in Merkel Cell Carcinoma Immunotherapy Should Be First Line in Merkel Cell Carcinoma
Pembrolizumab demonstrated durable tumor control, a generally manageable safety profile, and favorable survival outcomes compared with historical data in advanced MCC.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 18, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Chemo for Early-Stage Prostate Cancer? RTOG 0521 Says Maybe Chemo for Early-Stage Prostate Cancer? RTOG 0521 Says Maybe
In major clinical trial, docetaxel, which is typically used in metastatic disease, improved outcomes in high-risk, early-stage disease. However, the survival results fell short of the trial target.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 18, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Avelumab Combo Falls Short in Advanced Ovarian Ca
(MedPage Today) -- But showed promise in PD-L1-positive group (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 18, 2019 Category: Hematology Source Type: news

Lifestyle Changes Do a Number on PSA Values Lifestyle Changes Do a Number on PSA Values
Two month's abstinence from a few of life's pleasures obviated the need for prostate biopsy in nearly half of men who adopted the lifestyle changes.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 18, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Slow Medicine: Vaping a Smokescreen?
(MedPage Today) -- A take on e-cigarettes for smoking cessation (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 18, 2019 Category: Hematology Source Type: news

Dosing Adjuvant Chemo in Breast Cancer: Focus on Obesity Dosing Adjuvant Chemo in Breast Cancer: Focus on Obesity
Chemotherapy overdose may be avoided in obese patients with breast cancer using a tailored dosing strategy.Annals of Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 18, 2019 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Lung-Cancer Screens Effective in Asbestos-Exposed Smokers Lung-Cancer Screens Effective in Asbestos-Exposed Smokers
Low-dose computed tomography (LDCT) screening can detect early lung cancers in smokers with a history of occupational asbestos exposure, new research shows.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - March 18, 2019 Category: Pathology Tags: Hematology-Oncology News Source Type: news

Fewer T1 Melanoma Nodal Biopsies After 2009 Staging Manual Fewer T1 Melanoma Nodal Biopsies After 2009 Staging Manual
The overall number of T1 melanomas undergoing nodal biopsy have decreased following the 7th edition of the AJCC Cancer Staging Manual (AJCC 7), according to a new study.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - March 17, 2019 Category: Pathology Tags: Hematology-Oncology News Source Type: news

PARP Inhibitor Benefit Gets a TWiST in Recurrent Ovarian Ca
(MedPage Today) -- Analysis attempts to quantify patients'quality of survival (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 17, 2019 Category: Hematology Source Type: news